TOP2A and pancreatic adenocarcinoma: In research of forecasting gemcitabine sensitivity with pancreatic adenocarcinomas patient objects, a different expression of TOP2A was discovered in gemcitabine sensitive tumors which authenticated as one of potential genes linked with resistance to drug [39].